This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Tetsuya Toge: Innovator in Hepatic Metastases Research
Introduction
Tetsuya Toge is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His innovative work focuses on developing compositions that can suppress hepatic metastases of tumors.
Latest Patents
Tetsuya Toge holds a patent for "Suppressory compositions against hepatic metastases of tumors." This invention provides suppressory compositions that comprise a phosphoric acid diester compound, which can be used to combat the spread of tumors to the liver. The patent highlights the potential for improved treatment options for patients suffering from this serious condition. He has 1 patent to his name.
Career Highlights
Tetsuya Toge is associated with Senju Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research has the potential to impact the lives of many patients facing cancer challenges.
Collaborations
Tetsuya has collaborated with notable colleagues, including Toshihiro Hirai and Akihiro Yoshimoto. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Tetsuya Toge's work exemplifies the spirit of innovation in medical research. His contributions to suppressing hepatic metastases of tumors highlight the importance of ongoing research in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile